Literature DB >> 16552613

[Patient knowledge regarding tardive dyskinesia].

E M Haberfellner1, H Rittmannsberger.   

Abstract

BACKGROUND: Patients can provide appropriate and legally valid consent to treatment with antipsychotics only if they received adequate information on the risk of tardive dyskinesia (TD) and have the capacity to give informed consent.
METHODS: Eighty-seven patients in a psychiatric practice undergoing treatment with antipsychotics were interviewed for their level of information regarding TD and were subsequently provided with additional information on TD as needed. Three months after provision of this information, the interview was repeated.
RESULTS: Though 82% of the patients had read the patient information leaflet and 44% had already received previous information, only 17% were found to be informed. The proportion of informed patients increased to 72% at the second interview. Among patients remaining uninformed despite previous information, a statistically significant higher proportion of elderly patients and patients with marked psychopathological impairments was found.
CONCLUSIONS: Schizophrenic patients' knowledge on TD is low. With appropriate oral information being provided patients' knowledge can be considerably improved in the short run.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16552613     DOI: 10.1007/s00115-005-1897-6

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  22 in total

Review 1.  Informed consent and the capacity for voluntarism.

Authors:  Laura Weiss Roberts
Journal:  Am J Psychiatry       Date:  2002-05       Impact factor: 18.112

2.  [Informed consent in psychiatry--European standards and differences, problems and recommendations].

Authors:  H Helmchen
Journal:  Fortschr Neurol Psychiatr       Date:  1997-01       Impact factor: 0.752

3.  Informed consent and tardive dyskinesia.

Authors:  I Kleinman; D Schachter; E Koritar
Journal:  Am J Psychiatry       Date:  1989-07       Impact factor: 18.112

4.  Is it best to obtain informed consent from schizophrenic patients about the possible risk of drug treatment, for example, tardive dyskinesia, before initiating treatment or at a later date?

Authors:  L H Roth
Journal:  J Clin Psychopharmacol       Date:  1983-06       Impact factor: 3.153

5.  Informing patients about tardive dyskinesia.

Authors:  M R Munetz; L H Roth
Journal:  Arch Gen Psychiatry       Date:  1985-09

6.  Effectiveness of two methods for informing schizophrenic patients about neuroleptic medication.

Authors:  I Kleinman; D Schachter; J Jeffries; P Goldhamer
Journal:  Hosp Community Psychiatry       Date:  1993-12

7.  A study of the capacity of schizophrenic patients to give informed consent.

Authors:  L Grossman; F Summers
Journal:  Hosp Community Psychiatry       Date:  1980-03

8.  Evaluation of patient knowledge regarding oral anticoagulants.

Authors:  G Roche-Nagle; F Chambers; J Nanra; D Bouchier-Hayes; S Young
Journal:  Ir Med J       Date:  2003 Jul-Aug

Review 9.  Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies.

Authors:  Christoph U Correll; Stefan Leucht; John M Kane
Journal:  Am J Psychiatry       Date:  2004-03       Impact factor: 18.112

Review 10.  Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence.

Authors:  John M Kane
Journal:  J Clin Psychiatry       Date:  2004       Impact factor: 4.384

View more
  1 in total

Review 1.  [Documentation in psychiatry and psychotherapy: prerequisites and clinical practice].

Authors:  H Spiessl; H Hausner; G Hajak; C Cording
Journal:  Nervenarzt       Date:  2008-09       Impact factor: 1.214

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.